Skip to main content

HEAL Committee Meeting

Notices of Meeting include information about the subject matter to be examined by the committee and date, time and place of the meeting, as well as a list of any witnesses scheduled to appear. The Evidence is the edited and revised transcript of what is said before a committee. The Minutes of Proceedings are the official record of the business conducted by the committee at a sitting.

For an advanced search, use Publication Search tool.

If you have any questions or comments regarding the accessibility of this publication, please contact us at accessible@parl.gc.ca.

Previous day publication Next day publication

MINUTES OF PROCEEDINGS

Meeting No. 42

THURSDAY, May 14, 1998

The Standing Committee on Health met in a televised session at 9:29 o’clock a.m., this day, in Room 253-D, Centre Block, the Chair, Beth Phinney, presiding.

Members of the Committee present: Carolyn Bennett, Elinor Caplan, Aileen Carroll, Maurice Dumas, Reed Elley, Lynn Myers, Maurice Vellacott, Joseph Volpe, Judy Wasylycia-Leis.

Acting Members present: John O’Reilly for Claude Drouin, Roger Gallaway for Dan McTeague, Gar Knutson for Rose-Marie Ur, Keith Martin for Grant Hill.

In attendance: From the Research Branch of the Library of Parliament: Odette Madore, Nancy Miller-Chenier and Gérald Lafrenière, Research Officers.

Pursuant to Standing Order 108(2), the Committee resumed consideration of natural health products. (See Minutes of Proceedings dated Thursday, November 20, 1997.)

Witnesses: From the Department of Health (United Kingdom):Richard Woodfield, Group Manager, Medicines Control Agency. From the Chemicals and Non-Prescription Drug Branch (Australia): Laurayne Bowler, Acting Director. From the Federal Institute for Drugs and Medical Devices via videoconference from Germany: Dr. Konstantin Keller, Director. From Health Canada (Health Protection Branch): Dann Michols, Director General, Therapeutic Products Programme. From Health Canada (Food Directorate): Ron Burke, Acting Director, Bureau of Food Regulatory, Interagency and Intergovernmental Affairs; Dr. Margaret Cheney, Chief, Nutrition Evaluation Division; Harry Conacher, Acting Director, Bureau of Chemical Safety.

Richard Woodfield, Laurayne Bowler and Konstantin Keller made opening statements and with the other witnesses answered questions.

At 11:55 the sitting was suspended.

At 12:00 the sitting resumed.

By unanimous consent, it was agreed that Lynn Myers be allowed to move the following motion -- That the motion adopted by the Committee during its May 5th meeting, dealing with the language of motions presented in Committee, be rescinded.

Keith Martin moved, -- That the motion be amended by adding after the word "rescinded", the following:

"And that the Committee table a report in the House containing a description of the events surrounding the adoption of the said motion."

After debate, the question being put on the amendment, it was, by a show of hands, negatived: YEAS: 2; NAYS: 6;

The question being put on the main motion, it was, by a show of hands, agreed to: YEAS: 6; NAYS 2;

Keith Martin moved, -- That the Health Committee invite the Health Minister and Health Canada officials to appear before the Committee to respond to questions relating to M-222, and report on progress made in the area of organ transplantation since the unanimous adoption of M-222 in the House of Commons on October 9, 1997.

After debate, the question being put on the motion, it was agreed to.

It was agreed, -- That the proposed budget submission for the Committee’s natural health products study be adopted.

At 12:20 o’clock p.m., the Committee adjourned to the call of the Chair.

 

 

 

 

ROGER PRÉFONTAINE

Clerk of the Committee